These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7082587)

  • 21. Inherited deficiency of antithrombin III in an Italian kindred.
    Tripodi A; Boyer C; Canciani MT; D'Angelo A; Mannucci PM
    Ric Clin Lab; 1980; 10(3):521-9. PubMed ID: 6775364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An abnormal plasma antithrombin with no apparent affinity for heparin.
    Chasse JF; Esnard F; Guitton JD; Mouray H; Perigois F; Fauconneau G; Gauthier F
    Thromb Res; 1984 May; 34(4):297-302. PubMed ID: 6204398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functional abnormal antithrombin III (AT III) deficiency: AT III Charleville.
    Aiach M; Nora M; Fiessinger JN; Roncato M; François D; Gelas MA
    Thromb Res; 1985 Sep; 39(5):559-70. PubMed ID: 4082101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.
    Griffith MJ; Carraway T; White GC; Dombrose FA
    Blood; 1983 Jan; 61(1):111-8. PubMed ID: 6184096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of congenital antithrombin III deficiency with concentrates.
    Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ
    Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.
    Girolami A; Fabris F; Cappellato G; Sainati L; Boeri G
    Blut; 1983 Aug; 47(2):93-103. PubMed ID: 6871478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of familial antithrombin III variant complicated by recurrent pulmonary infarction].
    Nakano Y; Sato A; Okano A; Chida K; Yasumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):214-8. PubMed ID: 8515601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tentative classification of AT III congenital abnormalities.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):661-9. PubMed ID: 2448207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial deficiency of antithrombin III: evidence for heterogeneity existing within the family.
    d'Souza S; Ekert H
    Aust N Z J Med; 1984 Dec; 14(6):835-40. PubMed ID: 6598052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of hereditary heparin co-factor II deficiency with thrombosis.
    Tran TH; Marbet GA; Duckert F
    Lancet; 1985 Aug; 2(8452):413-4. PubMed ID: 2863444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.
    de Roux N; Chadeuf G; Molho-Sabatier P; Plouin PF; Aiach M
    Br J Haematol; 1990 Jun; 75(2):222-7. PubMed ID: 2372510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.
    Koide T; Takahashi K; Odani S; Ono T; Sakuragawa N
    Thromb Res; 1983 Jul; 31(2):319-28. PubMed ID: 6636046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.